UPDATE: Medicines Co. (MDCO) Says Milano Study Interim Data Inconclusive - Bloomberg

August 30, 2016 4:26 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
(Updated - August 30, 2016 4:30 PM EDT)

Medicines Co. (NASDAQ: MDCO) said interim analysis of the first 40 patients completing treatment in its Milano-Pilot study didn't meet the pre-defined efficacy threshold to stop early, according to Bloomberg. The company had hoped the analysis would allow early termination of the study, but so far data is "inconclusive."

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, FDA, Management Comments

Add Your Comment